- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
By Jonathan D. Salant for NJ.com
New Jersey, about to embark on an expansion of medical marijuana, received higher marks this year than in the past from a group that supports access to cannabis for medical use.
Americans for Safe Access gave the Garden State a B, up from C the past three years, in its annual report card. The report was released Tuesday as the National Conference of State Legislatures gathered in Nashville for its annual meeting.
David Mangone, director of government affairs, said the report’s timing was designed to give state lawmakers “clear ways to improve access to medical cannabis."
Illinois and Oregon received the highest grades awarded by the group, A-. California, Hawaii, Maine, Massachusetts, Michigan, Nevada and New Mexico also scored higher than New Jersey, receiving grades of B+.
More than one-third of the states, 17, received failing grades: Alabama, Georgia, Idaho, Indiana, Iowa, Kansas, Kentucky, Mississippi, North Carolina, South Carolina, South Dakota, Tennessee, Texas, Virginia, West Virginia, Wisconsin and Wyoming.
While the report was issued before the New Jersey Legislature, the state saw its grade improve because it added new categories, including chronic pain, to qualify for medical marijuana, and announced plans to expand the number of dispensaries.
It also received its highest scores for protecting patients’ privacy and for allowing those in need of medical cannabis to qualify to get the drug.
New Jersey has more than 51,000 medical marijuana patients.
Gov. Phil Murphy signed legislation last month to expand medical marijuana, including adding dozens of new providers and making it easier for patients to get the drug.